Basal cell carcinoma
Revolutionizing The Treatment Of Cancer
In Phase 1 clinical studies at U.C. Davis Medical Center, the Photometics “laser technology” showed significant promise in the treatment of basal cell carcinoma – the most common form of skin cancer, affecting an estimated 4.3 million Americans a year.
Our patented selective photo-apoptosis technology is based on decades of research into differential infrared absorption to deliver the precise characteristics of light energy needed to kill cancer cells while leaving the surrounding tissue healthy and intact.
The vision of our founder Brian Pierce delivered in his TEDx Talk: Shedding Light on Cancer.